Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 东北制药集团股份有限公司是一家以制造和销售化学原料药品、制剂药品为主业的企业.公司主要从事药品生产与流通。 | ||||||||||||||||||||||||
Main Business | 主要业务覆盖化学制药(原料药、制剂)、医药商业(批发、连锁)、医药工程(医药设计、制造安装)、生物医药(生物诊断试剂)等板块,形成了医药上下游产业及服务集群。 | ||||||||||||||||||||||||
Legal Representative | 郭建民 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 宋家纶 | ||||||||||||||||||||||||
Solicitors | 北京金诚同达律师事务所 | ||||||||||||||||||||||||
Auditors | 瑞华会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 024-25806963 | ||||||||||||||||||||||||
Fax No | 024-25806400 | ||||||||||||||||||||||||
Website | www.nepharm.com.cn | ||||||||||||||||||||||||
dshbgs@nepharm.com.cn | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 23/05/1996 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.250 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 0.100 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 3.490 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 7.527B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |